Important Announcements

arrow icon

The Ministry of Health (MOH) has developed a Cancer Drug List (CDL) comprising clinically proven and more cost-effective cancer treatments. From 1 September 2022, MediShield Life (MSHL) and MediSave (MSV) will only cover treatments on the CDL. For all Integrated Shield Plans (IPs), the CDL will take effect from 1 April 2023, upon the renewal of your policy. Customers with riders can claim for selected cancer drug treatments beyond the CDL.

Upon renewal of your policy, the outpatient Chemotherapy and Immunotherapy benefit will be replaced with a new outpatient Cancer Drug Treatment benefit and Cancer Drug Services benefit:

  • Cancer Drug Treatment benefit – Only outpatient cancer drug treatments on the CDL will be claimable under your Policy, up to the treatment-specific benefit limits. Selected outpatient cancer drug treatments beyond the CDL will be claimable under riders. If you require cancer treatment following the changes, please consult your doctor early on whether your treatment is on the CDL.
  • Cancer Drug Services benefit – Services that are part of any outpatient cancer drug treatment (including services for treatments not on the CDL), such as consultations, scans, lab investigations, treatment preparation and administration, supportive care drugs and blood transfusions, will be claimable under the Cancer Drug Services benefit, up to specified benefit limits.

We will also be introducing a new Additional Cancer Drug Treatment benefit for your rider from 1 April 2023 to supplement your coverage on outpatient cancer drug treatments:

  • Additional Cancer Drug Treatment benefit – Outpatient cancer drug treatments on the CDL, and non-CDL treatments under drug classes A to E, will be claimable under your rider, up to the treatment-specific benefit limits for CDL treatments and monthly limits for non-CDL treatments. A co-payment is payable for each claim, and it will vary according to the type of cancer drug treatment.

On CDL: For outpatient cancer drug treatments on the CDL, the rider benefit limit will be an additional 200% of your respective Policy benefit limit on Cancer Drug Treatment. This rider benefit limit will be on top of your respective Policy benefit limit on Cancer Drug Treatment. The co-payment based on your rider will apply. For treatment provided by our panel or extended panel, the co-payment limit will be up to $3,000 for each policy year. 

On non-CDL under drug classes from A to E: For outpatient cancer drug treatments classified as non-CDL under drug classes A to E, the rider benefit limit will be up to $15,000 (each month), according to your respective Policy. The co-payment based on your rider will apply and it will not have any co-payment limit.

Click here to view the Policy and rider benefit limits and coverage under each of the above benefits.

To view a sample of our one time communication letter for Enhanced IncomeShield and Deluxe Care Rider, click here; for Enhanced IncomeShield and Classic Care Rider, click here.

For more information, please read our FAQs here.

From 1 Sep 2022, MediShield Life will shift to cover a Cancer Drug List (CDL) of clinically proven and more cost-effective outpatient cancer drug treatments. This will help ensure greater affordability of cancer treatments and insurance in the longer term.

Prior to 1 Sep 2022, patients could claim up to $3,000 per month under MediShield Life for all outpatient cancer drug treatments and related services. From 1 Sep 2022, the claim limits will range from $200 to $9,600 per month depending on the cancer drug treatment. An additional $3,600 per year is claimable for cancer drug services.

All Integrated Shield Plans (IPs) will also follow the CDL and introduce claim limits, when policyholders purchase or renew their policies from 1 April 2023. IPs will not cover treatments not on the CDL. Riders will cover selected treatments not on the CDL, to varying extents. More details on IP and rider coverage of cancer drug treatments and services have been shared with policyholders in end 2022.

For more information, visit MOH’s website here.

As our borders progressively reopen to permit international travel, MOH is allowing Singapore Citizens and PRs who travel out of Singapore to claim for inpatient COVID-19 treatment from MediShield Life and Integrated Shield Plans on or after 20 Oct 2020, should they experience onset of COVID-19 symptoms within 14 days of their return to Singapore.

To support COVID-19 vaccination in Singapore, all IncomeShield plans will cover hospitalisation due to COVID-19 vaccination if it becomes necessary. The COVID-19 vaccination must be:

i. Approved by the Health Sciences Authority and administered in Singapore; or

ii. Approved under the Special Access Route and approved by the World Health Organisation under its Emergency Use Listing, where the use of such vaccines should be in line with its accompanying guidelines and recommended use, and administered by approved providers licensed by the Ministry of Health.

Did You Know

Here’s how Enhanced IncomeShield complements your MediShield Life coverage.

Enjoy these additional benefits.

Pick the plan that meets your needs.




For a more detailed look at what you are covered for, you may view the full coverage table here.

If you are a Singaporean Citizen or Permanent Resident, you may apply for this plan online.

Understand more about how each plan can meet your unique needs.

What our customers have said about us!

Side Banner Image

Your policy toolkit.

To apply or upgrade to Enhanced IncomeShield, the last entry age is 75 (based on the insured's age next birthday). 

To apply for Deluxe Care Rider or Classic Care Rider, the last entry age is 75 (based on the insured's age next birthday). The plan selected for the Deluxe Care Rider or Classic Care Rider must be the same as your Enhanced IncomeShield plan.

You need to make payment every year.

View full premium table for Main Plan

View full premium table for Deluxe Care Rider

View full premium table for Classic Care Rider

You may refer to MOH’s website for a comparison of Integrated Shield Plans (IPs) across all insurers, including the estimated premiums you have to pay for an IP over your lifetime.

Learn more about the drivers of premium here.

Ways to pay for Enhanced IncomeShield.

Find out how you can make payment for your policy by choosing from the preferred methods below. For other accepted payment modes, you may get in touch with us through your preferred mode of contact at

Your queries answered.

The best deals. Just for you.


Get advice tailored to your needs.

We are here to help. Leave your contact details below and one of our Income Advisors will reach out to you in 3 working days.

By providing and submitting the information, I give my consent and agree to Income Insurance Limited, its representative, agents (collectively “Income”) and its third party service provider(s) acting on behalf of Income in collecting, using and disclosing my personal data (including any update that I have given to Income) to contact me for marketing & promotional information relating to products and/or services offered and/or distributed by Income via email, call, and/or text messages/SMS.

I understand that the consent provided by me in this form is in addition to and does not supersede any consent which I may have provided previously in respect of the above purposes, unless my consent is withdrawn and notified to Income. I may withdraw my marketing consent given by email to Please refer to Income's Privacy Policy for more information, including access and correction of my personal data and consent withdrawal.

If I have notified Income that I am withdrawing my consent, I understand that my request will be effected within 10 days and I will stop receiving marketing messages after 21 days for the selected mode(s) of communication. I agree that I will continue to receive marketing messages via other modes of communication or on specific product(s) or services where my consent has been given to Income unless such consent has been withdrawn.